Truist Securities Reiterates Buy on Progyny, Raises Price Target to $42

Benzinga · 1d ago
Truist Securities analyst Jailendra Singh reiterates Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $36 to $42.